1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Combating Social Isolation of Older Adults Grant (Grant Cycle #3) is sponsored by The Sephardic Foundation on Aging. This grant aims to combat elder abuse and neglect exacerbated by social isolation. It promotes trauma-informed care and mental health services to help older adults reconnect socially and supports intergenerational programming to foster community connections and reduce isolation.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofit organizations with 501(c)3 tax-exempt status or a fiscal sponsor, in operation for at least two years, supporting older adults in priority areas. Confirm the full requirements in the official notice before applying.
The current listing shows unspecified (Previous average awards of $91,549 for similar grants). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Combating Social Isolation of Older Adults Grant (Grant Cycle #3) is funded by The Sephardic Foundation on Aging. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article